Kenneth Cusi
Impact in
- Endocrinology, Diabetes and Metabolism top 0.01%
- Diet, Metabolism, and Disease
- Diabetes Treatment and Management
- Epidemiology top 0.01%
- Liver Disease Diagnosis and Treatment
Papers in
- Epidemiology 148
- Liver Disease Diagnosis and Treatment 142
-
- Diet, Metabolism, and Disease 54
- Co-authors
- Arun J. Sanyal (18 shared papers)Zobair M. Younossi (18 shared papers)Naga Chalasani (5 shared papers)Michael Charlton (5 shared papers)Elizabeth M. Brunt (4 shared papers)Joel E. Lavine (4 shared papers)Stephen A. Harrison (23 shared papers)Fernando Bril (57 shared papers)
- Journals
- The Journal of Clinical Endocrinology & Metabolism (18 papers)Diabetes Care (18 papers)Journal of Hepatology (14 papers)Hepatology (12 papers)Diabetes (11 papers)
- Partner nations
- United StatesItalyFrance
In The Last Decade
Kenneth Cusi
215 papers receiving 33.6k citations
Kenneth Cusi's Hit Papers
Peers
Comparison fields: 5 of 159
- Endocrinology, Diabetes and Metabolism 10.8k
- Epidemiology 21.3k
- Hepatology 4.4k
- Physiology 5.6k
- Pathology and Forensic Medicine 2.1k
Countries citing papers authored by Kenneth Cusi
This map shows the geographic impact of Kenneth Cusi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth Cusi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth Cusi more than expected).
Fields of papers citing papers by Kenneth Cusi
This network shows the impact of papers produced by Kenneth Cusi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth Cusi. The network helps show where Kenneth Cusi may publish in the future.
Co-authors
The 25 scholars most cited alongside Kenneth Cusi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 223 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases Hit paper breakdown → | 2017 | 5284 |
| 2 | The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association Hit paper breakdown → | 2012 | 3064 |
| 3 | Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 Hit paper breakdown → | 2003 | 1601 |
| 4 | The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology Hit paper breakdown → | 2012 | 1413 |
| 5 | A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis Hit paper breakdown → | 2006 | 1413 |
| 6 | A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis Hit paper breakdown → | 2020 | 1324 |
| 7 | Insulin resistance differentially affects the PI 3-kinase– and MAP kinase–mediated signaling in human muscle Hit paper breakdown → | 2000 | 857 |
| 8 | Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus Hit paper breakdown → | 2016 | 753 |
| 9 | Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications Hit paper breakdown → | 2012 | 692 |
| 10 | American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings Hit paper breakdown → | 2022 | 643 |
| 11 | Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies Hit paper breakdown → | 2018 | 641 |
| 12 | Effect of Pioglitazone on Abdominal Fat Distribution and Insulin Sensitivity in Type 2 Diabetic Patients Hit paper breakdown → | 2002 | 583 |
| 13 | Relationship Between Hepatic/Visceral Fat and Hepatic Insulin Resistance in Nondiabetic and Type 2 Diabetic Subjects Hit paper breakdown → | 2007 | 484 |
| 14 | The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association Hit paper breakdown → | 2012 | 433 |
| 15 | Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease Hit paper breakdown → | 2018 | 417 |
| 16 | High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels Hit paper breakdown → | 2015 | 396 |
| 17 | 2003 | 391 | |
| 18 | Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease Hit paper breakdown → | 2021 | 380 |
| 19 | 1996 | 362 | |
| 20 | 2011 | 360 |
About Kenneth Cusi
Kenneth Cusi is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism, Molecular Biology, Physiology and Surgery, having authored 223 papers that have together received 34.3k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (142 papers), Diet, Metabolism, and Disease (54 papers), Metabolism, Diabetes, and Cancer (28 papers), Diet and metabolism studies (22 papers), Adipose Tissue and Metabolism (15 papers), Pancreatitis Pathology and Treatment (14 papers), Alcohol Consumption and Health Effects (14 papers) and Liver Disease and Transplantation (14 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (10.8k citations), Epidemiology (21.3k citations), Hepatology (4.4k citations), Physiology (5.6k citations) and Pathology and Forensic Medicine (2.1k citations). Kenneth Cusi has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Arun J. Sanyal, Zobair M. Younossi, Naga Chalasani, Michael Charlton, Elizabeth M. Brunt, Joel E. Lavine, Stephen A. Harrison, Fernando Bril, Ralph A. DeFronzo and Mary E. Rinella. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care, Journal of Hepatology, Hepatology and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.